Peter Svennilson, Director at Revolution Medicines, Inc. (RVMD), sold 156,511 shares at $46.65 ($7.4M) on 2021-04-05, disclosed to the SEC on 2021-04-07.
Open-market sale of $7.4M RVMD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.65 | 8,554 | $399K | 5.4% |
| 2 | $46.65 | 8,554 | $399K | 5.4% |
| 3 | $46.65 | 9,661 | $451K | 6.1% |
| 4 | $46.65 | 9,661 | $451K | 6.1% |
| 5 | $48.06 | 18,551 | $892K | 12.1% |
| 6 | $48.06 | 18,551 |
| $892K |
| 12.1% |
| 7 | $48.06 | 20,949 | $1.0M | 13.7% |
| 8 | $48.06 | 20,949 | $1.0M | 13.7% |
| 9 | $45.60 | 13,128 | $599K | 8.1% |
| 10 | $45.60 | 13,128 | $599K | 8.1% |
| 11 | $45.60 | 14,825 | $676K | 9.2% |
| Total | $47.09 avg | 156,511 | $7.4M | 100% |
| Filing → |
| NGM | BUY | 2022-06-06 | $877K | — | Filing → |
| NGM | BUY | 2022-05-19 | $4.0M | — | Filing → |
| RAPT | SELL | 2021-08-24 | $5.4M | — | Filing → |